Reference health
How can we improve stroke thrombolysis rates? A review of health system factors and approaches associated with thrombolysis administration rates in acute stroke care
65/65 checkable references clean · checked 2026-07-23
Every reference with a DOI in the deposited reference list resolved to a known work in Crossref or DataCite at the dated check, and none carried a retraction, withdrawal, or removal notice.
14 without a DOI — not checked. A reference deposited without a DOI is never matched by title or guessed at; it stays outside the checked set, and this line discloses that.
The 65 checked references that resolve
resolves10.1161/01.STR.0000012515.66889.24
Long-Term Disability After First-Ever Stroke and Related Prognostic Factors in the Perth Community Stroke Study, 1989–1990
resolves10.1001/jama.2013.6959
Time to Treatment With Intravenous Tissue Plasminogen Activator and Outcome From Acute Ischemic Stroke
resolves10.1016/S1474-4422(10)70165-4
Implementation and outcome of thrombolysis with alteplase 3–4·5 h after an acute stroke: an updated analysis from SITS-ISTR
resolves10.1161/STROKEAHA.113.000995
Relationship Between Onset-to-Door Time and Door-to-Thrombolysis Time
resolves10.5694/j.1326-5377.2008.tb02114.x
Improving access to acute stroke therapies: a controlled trial of organised pre‐hospital and emergency care
resolves10.1136/bmj.a1655
Developing and evaluating complex interventions: the new Medical Research Council guidance
resolves10.1016/j.jstrokecerebrovasdis.2011.04.012
Barriers to the Use of Intravenous Tissue Plasminogen Activator for In-hospital Strokes
resolves10.1093/ageing/afh064
A systematic review of barriers to delivery of thrombolysis for acute stroke
resolves10.1016/j.surg.2004.06.019
Diffusion of new technology in health care: The case of aorto-iliac occlusive disease
resolves10.1016/j.ecolecon.2004.12.027
A tale of two market failures: Technology and environmental policy
resolves10.1186/1748-5908-6-42
The behaviour change wheel: A new method for characterising and designing behaviour change interventions
resolves10.1161/STROKEAHA.110.612358
Recombinant Tissue-Type Plasminogen Activator Use for Ischemic Stroke in the United States
resolves10.52964/AMJA.0443
The workload of stroke thrombolysis: A prospective study in a district general hospital setting
resolves10.1212/01.WNL.0000150903.38639.E1
Do the Brain Attack Coalition’s criteria for stroke centers improve care for ischemic stroke?
resolves10.1161/STROKEAHA.111.640060
Intravenous Thrombolysis for Stroke Increases Over Time at Primary Stroke Centers
resolves10.1212/WNL.0b013e318234332d
The cost-effectiveness of telestroke in the treatment of acute ischemic stroke
resolves10.1161/STROKEAHA.109.192361
Recommendations for the Implementation of Telemedicine Within Stroke Systems of Care
resolves10.1161/CIRCULATIONAHA.108.783688
Get With the Guidelines–Stroke Is Associated With Sustained Improvement in Care for Patients Hospitalized With Acute Stroke or Transient Ischemic Attack
resolves10.1093/qjmed/hcr075
Do centres with well-developed protocols, training and infrastructure have higher rates of thrombolysis for acute ischaemic stroke?
resolves10.1161/STROKEAHA.109.574509
Stroke Team Remote Evaluation Using a Digital Observation Camera in Arizona
resolves10.1016/S1474-4422(08)70171-6
Efficacy of site-independent telemedicine in the STRokE DOC trial: a randomised, blinded, prospective study
resolves10.1016/j.jstrokecerebrovasdis.2012.01.012
Using Routine Data for Quality Assessment in NeuroNet Telestroke Care
resolves10.1111/j.1532-5415.2011.03707.x
Effectiveness of Thrombolysis with Intravenous Alteplase for Acute Ischemic Stroke in Older Adults
resolves10.1001/archinte.163.18.2198
Sustained Benefit of a Community and Professional Intervention to Increase Acute Stroke Therapy
resolves10.1016/S1474-4422(12)70311-3
A multilevel intervention to increase community hospital use of alteplase for acute stroke (INSTINCT): a cluster-randomised controlled trial
resolves10.1089/tmj.2011.0116
Efficacy of Telemedicine for Stroke: Pooled Analysis of the Stroke Team Remote Evaluation Using a Digital Observation Camera (STRokE DOC) and STRokE DOC Arizona Telestroke Trials
resolves10.1161/JAHA.113.000336
Association of Geographical Factors With Administration of Tissue Plasminogen Activator for Acute Ischemic Stroke
resolves10.1016/j.jstrokecerebrovasdis.2013.07.043
National Survey of Thrombolytic Therapy for Acute Ischemic Stroke in Taiwan 2003-2010
resolves10.1016/j.jstrokecerebrovasdis.2013.06.033
Factors Associated with the Administration of Tissue Plasminogen Activator for Acute Ischemic Stroke
resolves10.1016/j.jstrokecerebrovasdis.2005.01.004
Tissue Plasminogen Activator Use: Evaluation and Initial Management of Ischemic Stroke from an Iowa Hospital Perspective
resolves10.5694/j.1326-5377.2011.tb04191.x
A population‐based study of thrombolysis for acute stroke in South Australia
resolves10.1016/j.jstrokecerebrovasdis.2009.12.009
Distance From Home to Hospital and Thrombolytic Utilization for Acute Ischemic Stroke
resolves10.1111/j.1600-0404.2011.01616.x
Pre-hospital delays and intravenous thrombolysis in urban and rural areas
resolves10.1111/j.1747-4949.2012.00844.x
Utilization of Intravenous Thrombolysis is Increasing in the United States
resolves10.1161/01.STR.32.8.1832
Treatment With Tissue Plasminogen Activator and Inpatient Mortality Rates for Patients With Ischemic Stroke Treated in Community Hospitals
resolves10.1161/STROKEAHA.111.641795
Proportion of Patients Treated With Thrombolysis in a Centralized Versus a Decentralized Acute Stroke Care Setting
resolves10.1161/STROKEAHA.110.604249
Using Recombinant Tissue Plasminogen Activator to Treat Acute Ischemic Stroke in China
resolves10.1161/STROKEAHA.109.577106
Dissemination of Thrombolysis for Acute Ischemic Stroke Across a Nation
resolves10.1161/01.STR.0000065198.80347.C5
Frequency of Thrombolytic Therapy in Patients With Acute Ischemic Stroke and the Risk of In-Hospital Mortality
resolves10.1016/j.jns.2009.03.004
Stroke center characteristics which influence the administration of thrombolytic therapy for acute ischemic stroke: A national survey of stroke centers in Taiwan
resolves10.1016/j.jstrokecerebrovasdis.2012.05.002
Thrombolysis and Outcome of Young Stroke Patients Over the Last Decade: Insights From the Nationwide Inpatient Sample
resolves10.1016/j.jstrokecerebrovasdis.2012.12.001
Quality of Acute Ischemic Stroke Care in Thailand: A Prospective Multicenter Countrywide Cohort Study
resolves10.1212/01.wnl.0000436946.08647.b5
Thrombolytic utilization for ischemic stroke in US hospitals with neurology residency program
resolves10.1161/STROKEAHA.111.643437
Impact of Emergency Department Transitions of Care on Thrombolytic Use in Acute Ischemic Stroke
resolves10.1161/STROKEAHA.110.591081
Effect of Weekend Compared With Weekday Stroke Admission on Thrombolytic Use, In-Hospital Mortality, Discharge Disposition, Hospital Charges, and Length of Stay in the Nationwide Inpatient Sample Database, 2002 to 2007
resolves10.1097/MLR.0b013e3182294092
The Use and Misuse of Thrombolytic Therapy Within the Veterans Health Administration
resolves10.1016/j.jstrokecerebrovasdis.2011.06.018
Hospital Prenotification of Stroke Patients by Emergency Medical Services Improves Stroke Time Targets
resolves10.1161/CIRCOUTCOMES.112.965210
Emergency Medical Service Hospital Prenotification Is Associated With Improved Evaluation and Treatment of Acute Ischemic Stroke
resolves10.1016/j.jns.2012.02.004
Arrival by ambulance is associated with acute stroke intervention in young adults
resolves10.1161/JAHA.112.000071
Joint Commission Primary Stroke Centers Utilize More rt‐PA in the Nationwide Inpatient Sample
resolves10.1016/j.clineuro.2013.02.010
Prehospital transfer medicalization increases thrombolysis rate in acute ischemic stroke. A French stroke unit experience
resolves10.1161/CIRCOUTCOMES.113.000089
Patterns of Emergency Medical Services Use and Its Association With Timely Stroke Treatment
The 14 references without a DOI — listed, not checked
no DOI — not checkedMackay J, Mensah G. The atlas of heart disease and stroke. Geneva: WHO; 2004.
no DOI — not checkedAgency for Healthcare Research and Quality. Household component summary table. In: Medical Expenditure Panel Survey. U.S. Department of Health and Human Services. 2012. http://meps.ahrq.gov/mepsweb/ . Accessed 12 Nov 2012.
no DOI — not checkedAustralian Bureau of Statistics. Cardiovascular disease in Australia: a snapshot, 2004-05. Canberra: ABS; 2006.
no DOI — not checkedAustralian Institute of Health and Welfare. Australia’s health 2006. Report. Canberra: AIHW; 2006. Report No.:1032-6138.
no DOI — not checkedDeloitte Access Economics. The economic impact of stroke in Australia. Melbourne: NSF; 2013.
no DOI — not checkedNational Stroke Foundation. National stroke audit—acute services clinical audit report 2011. Report. Melbourne: NSF; 2011.
no DOI — not checkedRanta A, Chan C, Rump D, Cariga P, Anderson L. Safety and efficacy of stroke thrombolysis at a secondary provincial hospital in New Zealand. N Z Med J. 2012;125(1358):35–43.
no DOI — not checkedSalami S, Kolluru A, Al-Najafi S, Stover C, Mar A, Szpunar S, et al. Utilization and outcome of thrombolytic therapy for acute ischemic stroke: the St. John Hospital code stroke experience. J Clin Outcomes Manag. 2011;18(4):165–9.
no DOI — not checkedFDA. Alteplase product approval information—licensing action 6/18/96. 04/02/2009 ed: U.S. Food and Drug Administration; 1996.
no DOI — not checkedAdams HP, Brott TG, Furlan AJ, Gomez CR, Grotta J, Helgason CM, et al. Guidelines for thrombolytic therapy for acute stroke: a supplement to the guidelines for the management of patients with acute ischemic stroke: a statement for healthcare professionals from a special writing group of the stroke council. Am Heart Assoc Circ. 1996;94(5):1167–74.
no DOI — not checkedPopay J, Roberts H, Sowden A, Petticrew M, Arai L, Rodgers M, et al. Guidance on the conduct of narrative synthesis in systematic reviews, A product from the ESRC methods programme version. 2006. p. 1.
no DOI — not checkedAmerican Heart Association. Get With The Guidelines-Stroke. 2014. http://www.heart.org/HEARTORG/HealthcareResearch/GetWithTheGuidelines/Get-With-The-Guidelines-Stroke_UCM_306098_SubHomePage.jsp . Accessed 10 Jan 2014.
no DOI — not checkedPower M, Tyrrell PJ, Rudd AG, Tully MP, Dalton D, Marshall M, et al. Did a quality improvement collaborative make stroke care better? A cluster randomized trial. Implement Sci. 2014;9(40):9pp.
no DOI — not checkedCharipar R, Charipar E. Administration of tissue plasminogen activator for acute ischemic stroke in a rural Wisconsin hospital. Wis Med J. 2008;107(4):176–80.
What this badge says. CiteStamped means the CHECKABLE references of this
work were clean at the dated check: each resolved to a known work in a public registry, and none
carried a retraction notice at that time. It says nothing about the quality, findings,
or importance of the work itself, and nothing about references deposited without a DOI.
checked 2026-07-23 — re-checked daily as this page is visited; titles and statuses come from Crossref and DataCite and are not part of the signed record
Embed this badge
Both snippets point at the live badge image and link back to this page. The badge re-renders from the daily check, so an embed never goes stale by more than a day of visits.
<a href="https://citestamp.com/citestamped/10.1186/s13012-016-0414-6"><img src="https://citestamp.com/citestamped/10.1186/s13012-016-0414-6/badge.svg" alt="CiteStamped reference-health badge" width="460" height="64"></a>
[](https://citestamp.com/citestamped/10.1186/s13012-016-0414-6)